Mesco Pharmaceuticals Ltd vs ZYDUS LIFESCIENCES LTD

A side-by-side comparison of Mesco Pharmaceuticals Ltd (MESCOPHARM) and ZYDUS LIFESCIENCES LTD (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, ZYDUS LIFESCIENCES LTD leads MESCOPHARM vs ZYDUSLIFE on 9 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability04
  • Growth· not comparable
  • Size & financial health13

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

0.00
P/E ratio
23.02
0.00
P/B ratio
4.09
0.00%
Dividend yield
0.08%
₹0.00
EPS
₹50.09

Profitability

ZYDUSLIFE takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

0.00%
Return on equity
21.20%
0.00%
Return on capital
21.00%
0.00%
EBITDA margin
31.00%
0.00%
Net margin
18.87%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

Revenue CAGR (3Y) even
16.35%
Profit CAGR (3Y) even
34.80%

Size & financial health

ZYDUSLIFE takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹0 Cr
Market cap
₹1.18L Cr
₹0 Cr
Revenue
₹27,148 Cr
₹0 Cr
Net profit
₹5,124 Cr
0.00
Debt / equity
0.31
ZYDUS LIFESCIENCES LTD
  • + ["Company has delivered good profit growth of 18.8% CAGR over last 5 years"]
Mesco Pharmaceuticals Ltd full analysis ZYDUS LIFESCIENCES LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

MESCOPHARM vs ZYDUSLIFE: Share Price, Valuation & Which to Buy | DocStoX